Physician profile
Mark L Eldore
NPI 1134120256
$405.92
in general payments reported to CMS, 2019-2025
9 companies · $16.79 in 2025
The $16.79 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $85.38 · 2021: $19.46 · 2022: $18.61 · 2023: $34.32 · 2024: $23.51 · 2025: $16.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.35 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.35 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $156.08 | 2019-2023 | |
| Duchesnay USA Incorporated | $109.92 | 2019 | |
| Hologic Sales and Service, LLC | $37.97 | 2019-2020 | |
| Corium, LLC | $23.51 | 2024 | Azstarys |
| Sumitomo Pharma America, INC. | $19.27 | 2023 | Myfembree |
| Acella Pharmaceuticals, LLC | $16.79 | 2025 | NP Thyroid 60 |
| Allergan, INC. | $15.50 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.33 | 2020 | |
| Boston Scientific Corporation | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Eldore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.